As of August 2026, Boule Diagnostics AB is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Boule Diagnostics AB. Stock Analysis BDABF
United States Health Care Nano Cap
Boule Diagnostics AB engages in the development, manufacture, sale and marketing of instruments and consumable products for blood diagnostics. The company employs 183 full-time employees The company went IPO on 2011-06-23. The firm specializes in the development, manufacture and sale of complete blood count (CBC) systems in the field of hematology. The company provides reagents, cleaning products and blood calibrators and controls that are used in human and veterinarian laboratories, as well as analyzers and complementing accessories for hematology systems. The Company’s product portfolio comprises five brands: Clinical Diagnostic Solutions, Exigo, Medonic, Swelab and Quintus. The Company’s primary customer base comprises small and medium-sized hospitals, clinics, diagnostics firms and laboratories. Furthermore, It operates worldwide through a number of subsidiaries, such as Boule Medical AB, Boule Nordic AB, Clinical Diagnostic Solutions Inc and Boule Medical (Beijing) Co Ltd.
Boule Diagnostics AB (BDABF) Chart
Financial Metrics & Statements of Boule Diagnostics AB (BDABF)
FAQ's for Boule Diagnostics AB (BDABF)
As of August 2026, Boule Diagnostics AB BDABF is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Boule Diagnostics AB using these criteria to determine its compliance status.
Muslim investors may consider investing in Boule Diagnostics AB if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
Musaffa determines the Shariah status of Boule Diagnostics AB by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
The Shariah compliance status of Boule Diagnostics AB may be updated periodically when new financial statements, earnings reports, or business activity information become available.
Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
You can check the latest Shariah compliance status of Boule Diagnostics AB on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Boule Diagnostics AB (BDABF)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.